Everolimus | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Everolimus

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 20 USDMF, 11 CEP/COS, 2 JDMF, 3 EU WC, 10 KDMF, 17 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

350 FDF Dossiers, 56 FDA Orange Book, 16 Europe, 21 Canada, 48 Australia, 189 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, FOR SUSPENSION;ORAL - 2MG, TABLET, FOR SUSPENSION;ORAL - 3MG, TABLET, FOR SUSPENSION;ORAL - 5MG, TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 29 Direct Compression, 20 Disintegrants & Superdisintegrants, 19 Controlled & Modified Release, 18 Granulation, 15 Thickeners and Stabilizers, 15 Chewable & Orodispersible Aids, 13 Co-Processed Excipients, 13 Taste Masking, 10 Lubricants & Glidants, 6 Film Formers & Plasticizers, 5 Parenteral, 5 Empty Capsules, 5 Solubilizers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 2 Coloring Agents, 2 Rheology Modifiers

DIGITAL CONTENT

75 NEWS #PharmaBuzz

75 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 13 Finished Drug Prices, 22 Annual Reports

MARKET PLACE

18 APIs, 12 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 3 US Exclusivities, 43 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3NOVARTIS PHARM

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

NOVARTIS PHARM

The Generic Rx Session

Not Confirmed

02

NOVARTIS PHARM

The Generic Rx Session

Not Confirmed

03

NOVARTIS PHARM

The Generic Rx Session

Not Confirmed

Contact us
to update this info